Molecule to Market: Inside the outsourcing space Podcast Por Raman Sehgal arte de portada

Molecule to Market: Inside the outsourcing space

Molecule to Market: Inside the outsourcing space

De: Raman Sehgal
Escúchala gratis

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization.

Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist consulting firms. Our host Raman is an entrepreneur, investor, bestselling author, speaker and long time industry insider.

https://moleculetomarketpod.com

Copyright 2020 All rights reserved.
Ciencia Ciencias Biológicas
Episodios
  • CDMO & C-suite headwinds for 2026
    Jan 30 2026

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO/c-suite leaders from the CDMO space, who discuss the big headwinds for the pharmaceutical and biotechnology space for 2026.

    Show features:

    • Christiane Bardroff, Chief Operating Officer (COO) at Rentschler Biopharma SE
    • Philip Macnabb, Chief Executive Officer at Curia
    • Kaan-Fabian Kekec, Partner at Simon-Kucher‘s Healthcare & Life Sciences division
    • Dirk T. Lange , Chief Executive Officer at Pyramid Pharma Services Bruce Thompson, CTO at Kincell Bio
    • Bill Vincent, Biotech Entrepreneur, CEO, Board Member
    • Derek Hennecke - founder, investor, board member
    • Matthew Bio, CSO at Cambrex & President, Snapdragon Chemistry Stephen Dilly, CEO at Sonoma Biotherapeutics,
    • Stephen Dilly, CEO at Sonoma Biotherapeutics,
    • Bill Humphries, Chief Executive Officer at Medpharm
    • Elisabeth Stampa, CEO at Medichem SL
    • Kerstin Dolph, SVP of Manufacturing at Charles River Labs
    • Eric Edwards, Chief Executive Officer at Phlow-USA
    • Peter DeYoung, CEO at Piramal Pharma
    • Ian Tzeng, Managing Director at L.E.K. Consulting
    • Adam Siebert, Managing Director at L.E.K. Consulting
    • J.D. Mowery, President CDMO Division Bora Pharmaceuticals
    • Peter Belden President, US, Tjoapack
    • Nick Fortin, CEO CODIS

    Molecule to Market is also sponsored by Bora Pharmaceuticals and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

    Más Menos
    29 m
  • Insights from JPM
    Jan 23 2026

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with three senior leaders that attended The JPM's Annual Healthcare Conference 2026:

    • Chris Garabedian, CEO, Xontogeny and Portfolio Manager, PXV Fund
    • Dean McAlister, Executive Vice President, Inizio Biotech
    • Catherine Hunter, Head of Business Development at ramarketing

    Hear from experts who have seen multiple cycles and know the difference between noise and signal.We talk real confidence levels, what actually dominated conversations in San Francisco, where capital and opportunity are genuinely moving.

    Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

    Más Menos
    49 m
  • CDMO C-suite optimism pulse for 2026
    Jan 16 2026

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO/c-suite leaders from the CDMO space, who discuss the optimism levels for the pharmaceutical and biotechnology space for 2026.

    Guests include:

    • Christiane Bardroff, Chief Operating Officer (COO) at Rentschler Biopharma SE
    • Philip Macnabb, Chief Executive Officer at Curia
    • Kaan-Fabian Kekec, Partner at Simon-Kucher‘s Healthcare & Life Sciences division
    • Dirk T. Lange , Chief Executive Officer at Pyramid Pharma Services Bruce Thompson, CTO at Kincell Bio
    • Bill Vincent, Biotech Entrepreneur, CEO, Board Member
    • Derek Hennecke - founder, investor, board member
    • Matthew Bio, CSO at Cambrex & President, Snapdragon Chemistry Stephen Dilly, CEO at Sonoma Biotherapeutics,
    • Bill Humphries, Chief Executive Officer at Medpharm
    • Elisabeth Stampa, CEO at Medichem SL
    • Philip Lee, CEO at GeneFab
    • Kerstin Dolph, SVP of Manufacturing at Charles River Labs
    • Eric Edwards, Chief Executive Officer at Phlow-USA
    • Peter DeYoung, CEO at Piramal Pharma
    • Ian Tzeng, Managing Director at L.E.K. Consulting
    • Adam Siebert, Managing Director at L.E.K. Consulting
    • J.D. Mowery, President CDMO Division Bora Pharmaceuticals
    • Peter Belden President, US, Tjoapack

    Molecule to Market is also sponsored by Bora Pharmaceuticals and Charles River Laboratories, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

    Más Menos
    32 m
Todavía no hay opiniones